Our deal with Novo Nordisk has come in third place yesterday at the European Lifestars Awards - Celebrating Life Science Leaders in London. Thank you to our Novo colleagues, including Anu Balendran, for a great collaboration and fantastic evening. https://lnkd.in/dNeDbkCx
EraCal Therapeutics
Biotechnologieforschung
Basel, BS 1.993 Follower:innen
Towards an efficacious and well-tolerated appetite-suppressant using our innovative in-vivo screening platform
Info
The biotech-company EraCal Therapeutics Ltd. is a spin-off of the University of Zurich and Harvard University, and develops first-in-class drugs to treat different diseases.
- Website
-
http://www.eracal.ch
Externer Link zu EraCal Therapeutics
- Branche
- Biotechnologieforschung
- Größe
- 2–10 Beschäftigte
- Hauptsitz
- Basel, BS
- Art
- Privatunternehmen
- Gegründet
- 2018
Orte
-
Primär
Aeschengraben 13
Basel, BS 4051, CH
Beschäftigte von EraCal Therapeutics
Updates
-
We are thrilled to see our deal with Novo Nordisk has made the finals of the European Lifestars Awards - Celebrating Life Science Leaders. Looking forward to the ceremony in London next week. https://lnkd.in/dNeDbkCx
Finalists | European Lifestars Awards
informaconnect.com
-
Proud to be selected in the Top 5 of Swiss biotech scale-ups 2024. https://lnkd.in/dV2-eDzE
In the growth curve: Switzerland’s most promising scale-ups in 2024
top100startups.swiss
-
Congratulations to Pauline Pfirter MLaw, LL.M. who was unanimously elected to the board of directors of EraCal Therapeutics. Welcome to the team Pauline, we are looking forward to shaping the future of EraCal Therapeutics together. https://www.eracal.ch/news
-
Congratulations to Pauline Pfirter MLaw, LL.M. who was unanimously elected to the board of directors of EraCal Therapeutics. Welcome to the team Pauline, we are looking forward to shaping the future of EraCal Therapeutics together. https://www.eracal.ch/news
-
EraCal Therapeutics enters into a Collaboration and License Agreement with Novo Nordisk